IPO Boutique

KineMed, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on KineMed, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
KineMed, Inc.KNMD -
NASDAQ
$6.50-$7.50 $0.00 $0.004.5 million
Feltl and Company
Co-Manager(s):
MLV & Co., Laidlaw and Co.
Filing(s):

Filed 2014-01-07
Underwriters Changed 2014-05-16
Terms Added 2014-06-09



About KineMed, Inc. (adapted from KineMed, Inc. prospectus):
They are a commercial-stage company focused on applying our proprietary biomarker platform technology to drug development, prescription and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "KNMD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved